Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.
Servitje O, Climent F, Colomo L, Ruiz N, García-Herrera A, Gallardo F, Mercadal S, Pomares H, Muniesa C, Martin-Callizo C, Marcoval J, Rovira R, Estrach T, Pujol RM.
J Cutan Pathol. 2019 Mar;46(3):182-189. doi: 10.1111/cup.13399. Epub 2018 Dec 26.
Follicular mucinosis: a review.
Khalil J, Kurban M, Abbas O.
Int J Dermatol. 2021 Feb;60(2):159-165. doi: 10.1111/ijd.15165. Epub 2020 Sep 2.
The role of dermatoscopy and reflectance confocal microscopy in the assessment of relapsing secondary cutaneous follicular B-cell lymphoma.
Laghi A, Lee C, Witkowski A, Hsu M, Pellacani G, Ludzik J.
JAAD Case Rep. 2022 Apr 12;24:91-93. doi: 10.1016/j.jdcr.2022.03.035. eCollection 2022 Jun.
Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions.
Massone C, Fink-Puches R, Cerroni L.
J Am Acad Dermatol. 2016 Nov;75(5):1000-1006. doi: 10.1016/j.jaad.2016.05.039. Epub 2016 Jul 2.
Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype: Report of 2 Epstein-Barr Virus-Positive Cases.
Chiang CT, Chuang SS, Lin HF, Li WH, Chiang YY, Chen BJ.
Am J Dermatopathol. 2023 Feb 1;45(2):73-80. doi: 10.1097/DAD.0000000000002254. Epub 2022 Nov 7.
Cutaneous secondary follicular centre cell lymphoma in association with lymphoedema praecox.
Hills RJ, Ive FA.
Br J Dermatol. 1993 Aug;129(2):186-9. doi: 10.1111/j.1365-2133.1993.tb03526.x.
Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M, Ben-Rejeb H, Vergier B, Feldis M, Toty L, Nohra O, Beylot-Barry M, Gros A, Merlio JP, Parrens M.
J Cutan Pathol. 2014 Oct;41(10):797-801. doi: 10.1111/cup.12379. Epub 2014 Oct 18.
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group.
Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10.
TOX expression in cutaneous B-cell lymphomas.
Schrader AM, Jansen PM, Willemze R.
Arch Dermatol Res. 2016 Aug;308(6):423-7. doi: 10.1007/s00403-016-1654-7. Epub 2016 May 14.
Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Liao CW, Yen KY, Hsieh TC, Kao CH.
Clin Nucl Med. 2016 Sep;41(9):701-2. doi: 10.1097/RLU.0000000000001287.
